Lupus Foundation of America medical director, Dr. Joan Merrill, discusses a new study that analyzed lupus treatment data from past global clinical trials. The analysis was conducted by the Lupus Foundation of America to expand understanding of the impact that various background medications may have on clinical trials in lupus and to improve the design of future lupus clinical trials in order to secure a full arsenal of new treatments for lupus, an unpredictable and potentially fatal disease that affects millions of people worldwide.

свернуть